BRAINLIFE.ORG





Neuro-Oncology Reviews




Volume 26 Number 14
20 July 2024




Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 14, 20 July






Pichardo-Rojas PS, Pichardo-Rojas D, Marín-Castañeda LA, Palacios-Cruz M, Rivas-Torres YI, Calderón-Magdaleno LF, Sánchez-Serrano CD, Chandra A, Dono A, Karschnia P, Tonn JC, Esquenazi Y.
Prognostic value of surgical resection over biopsy in elderly patients with glioblastoma: a meta-analysis.
J Neurooncol. 2024 Jul 11. doi: 10.1007/s11060-024-04752-w. PMID: 38990444. Meta-analysis˰ ˍ




Del Baldo G, Carai A, Mastronuzzi A.
Chimeric antigen receptor adoptive immunotherapy in central nervous system tumors: state of the art on clinical trials, challenges, and emerging strategies to addressing them.
Curr Opin Oncol. 2024 Jul 12. doi: 10.1097/CCO.0000000000001076. PMID: 38989708. Review. ˍ




Bou-Gharios J, Noël G, Burckel H.
Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme.
Cell Death Dis. 2024 Jul 13;15(7):503. doi: 10.1038/s41419-024-06904-2. PMID: 39003252. Review. ˍ




Habibi MA, Ghorbani M, Esmaeilian S, Tajvidi F, Nekutalaban P, Boskabadi AR, Alemi F, Zafari R, Mirjani MS, Eazi S, Minaee P.
Stereotactic radiosurgery versus combined stereotactic radiosurgery and bevacizumab for recurrent glioblastoma; a systematic review and meta-analysis of survival.
Neurosurg Rev. 2024 Jul 13;47(1):323. doi: 10.1007/s10143-024-02585-9. PMID: 39002028. Review; Meta-analysis˰ ˍ




Sanikommu S, Panchawagh S, Eatz T, Lu VM, Rodrigues PB, Abdelsalam A, Gurses ME, Cummings A, Uppalapati V, Akurati S, Kondoor V, Komotar RJ, Ivan ME.
Recurrence of atypical and anaplastic intracranial Meningiomas: A meta-analysis of risk factors.
Clin Neurol Neurosurg. 2024 Jul 14;244:108450. doi: 10.1016/j.clineuro.2024.108450. PMID: 39018991. Meta-analysis˰ ˍ




Park JE, Park YW, Kim YH, Song SW, Hong CK, Kim JH, Kim HS.
Determining Progressive Disease Using RANO 2.0-Further Clarifications and Explanations.
Korean J Radiol. 2024 Jul 15. doi: 10.3348/kjr.2024.0476. PMID: 39028016. Comment. ˍ
RELATED ARTICLE
*Won SE, Suh CH, Kim S, Park HJ, Kim KW.
Summary of Key Points of the Response Assessment in Neuro-Oncology (RANO) 2.0.
Korean J Radiol. 2024 Apr 11. doi: 10.3348/kjr.2024.0016. PMID: 38627876. Editorial. ˍ




Schiff D.
Low-Grade Gliomas: A New Mutation, New Targeted Therapy, and Many Questions.
Neurology. 2024 Jul 15;103(3):e209688. doi: 10.1212/WNL.0000000000209688. PMID: 39008801. Review˰ ˍ




Zhao B, Yao L, Hatami M, Ma W, Skutella T.
Vaccine-based immunotherapy and related preclinical models for glioma.
Trends Mol Med. 2024 Jul 15:S1471-4914(24)00167-9. doi: 10.1016/j.molmed.2024.06.009. PMID: 39013724. Review. ˍ




Chai X, Zhang Y, Zhang W, Feng K, Jiang Y, Zhu A, Chen X, Di L, Wang R.
Tumor Metabolism: A New Field for the Treatment of Glioma.
Bioconjug Chem. 2024 Jul 16. doi: 10.1021/acs.bioconjchem.4c00287. PMID: 39013195. Review˰ ˍ




Power EA, Millesi E, Rechberger JS, Daniels DJ.
CAR-T cells for H3K27-altered diffuse midline gliomas: where do we stand?
Immunotherapy. 2024 Jul 17:1-4. doi: 10.1080/1750743X.2024.2373043. PMID: 39016046. Editorial˰ ˍ




Senger S, Radtke K, Oertel J.
Full Endoscopic Transcranial Resection of Meningiomas.
Adv Tech Stand Neurosurg. 2024 Jul 18;52:129-138. doi: 10.1007/978-3-031-61925-0_10. PMID: 39017791. Review; Book chapter˰ ˍ




Lin MD, Tsai AC, Abdullah KG, McBrayer SK, Shi DD.
Treatment of IDH-mutant glioma in the INDIGO era.
NPJ Precis Oncol. 2024 Jul 19;8(1):149. doi: 10.1038/s41698-024-00646-2. PMID: 39025958. Review. ˍ




Kamel R, Van den Berge D.
Radiotherapy for subependymal giant cell astrocytoma: time to challenge a historical ban? A case report and review of the literature.
J Med Case Rep. 2024 Jul 20;18(1):330. doi: 10.1186/s13256-024-04649-2. PMID: 39030575. Case report; Review. ˍ